ADARx’s $75 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal.ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now